GB1101366A - Pharmaceutical compositions and a process for the manufacture thereof - Google Patents

Pharmaceutical compositions and a process for the manufacture thereof

Info

Publication number
GB1101366A
GB1101366A GB37310/66A GB3731066A GB1101366A GB 1101366 A GB1101366 A GB 1101366A GB 37310/66 A GB37310/66 A GB 37310/66A GB 3731066 A GB3731066 A GB 3731066A GB 1101366 A GB1101366 A GB 1101366A
Authority
GB
United Kingdom
Prior art keywords
benzodiazepin
exchange resin
groups
acidic ion
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB37310/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1101366A publication Critical patent/GB1101366A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
GB37310/66A 1965-08-20 1966-08-19 Pharmaceutical compositions and a process for the manufacture thereof Expired GB1101366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1177965 1965-08-20

Publications (1)

Publication Number Publication Date
GB1101366A true GB1101366A (en) 1968-01-31

Family

ID=4376790

Family Applications (1)

Application Number Title Priority Date Filing Date
GB37310/66A Expired GB1101366A (en) 1965-08-20 1966-08-19 Pharmaceutical compositions and a process for the manufacture thereof

Country Status (14)

Country Link
JP (1) JPS507079B1 (enrdf_load_html_response)
BE (1) BE685589A (enrdf_load_html_response)
DE (1) DE1617513C3 (enrdf_load_html_response)
DK (1) DK111277B (enrdf_load_html_response)
ES (1) ES330391A1 (enrdf_load_html_response)
FI (1) FI45726C (enrdf_load_html_response)
FR (1) FR6063M (enrdf_load_html_response)
GB (1) GB1101366A (enrdf_load_html_response)
IL (1) IL26306A (enrdf_load_html_response)
IT (1) IT1053660B (enrdf_load_html_response)
MY (1) MY6900059A (enrdf_load_html_response)
NL (1) NL6610569A (enrdf_load_html_response)
NO (1) NO120752B (enrdf_load_html_response)
SE (1) SE351978B (enrdf_load_html_response)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175915A1 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A method for preparing resinates
EP1175914A3 (en) * 2000-07-27 2002-05-02 Rohm And Haas Company A resinate composition
EP1293209A1 (en) * 2001-09-17 2003-03-19 Rohm And Haas Company Oral pharmaceutical dosage forms with reduced potential for drug abuse
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175915A1 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A method for preparing resinates
EP1175914A3 (en) * 2000-07-27 2002-05-02 Rohm And Haas Company A resinate composition
KR100869486B1 (ko) * 2000-07-27 2008-11-19 롬 앤드 하스 캄파니 레지네이트 제조방법
EP1293209A1 (en) * 2001-09-17 2003-03-19 Rohm And Haas Company Oral pharmaceutical dosage forms with reduced potential for drug abuse
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation
CN1615156B (zh) * 2002-01-18 2012-05-30 罗门哈斯公司 制备树脂酸酯的方法

Also Published As

Publication number Publication date
DE1617513B2 (de) 1973-08-16
DE1617513C3 (de) 1974-04-18
FR6063M (enrdf_load_html_response) 1968-05-27
ES330391A1 (es) 1967-10-16
DK111277B (da) 1968-07-15
NO120752B (enrdf_load_html_response) 1970-11-30
IL26306A (en) 1970-02-19
FI45726B (enrdf_load_html_response) 1972-05-31
MY6900059A (en) 1969-12-31
IT1053660B (it) 1981-10-10
NL6610569A (enrdf_load_html_response) 1967-02-21
SE351978B (enrdf_load_html_response) 1972-12-18
FI45726C (fi) 1972-09-11
JPS507079B1 (enrdf_load_html_response) 1975-03-20
DE1617513A1 (de) 1970-12-23
BE685589A (enrdf_load_html_response) 1967-02-17

Similar Documents

Publication Publication Date Title
BE754111A (fr) Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation
IL35688A (en) Substituted n-allyl-2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
GB1263000A (en) 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it
GB1101366A (en) Pharmaceutical compositions and a process for the manufacture thereof
BE756725A (fr) Procede de preparation de 3,3,3-trifluoropropylmethylpolysiloxanes
FI51700C (fi) Menetelmä rauhoittavina lääkeaineina käyttökelpoisten 6-fenyyli-4H-s-t riatsolo-(1,5a)(1,4)-bentsodiatsepiinien valmistamiseksi.
IL35847A0 (en) New evomonoside derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
NL143271B (nl) Werkwijze ter bereiding van reukstofcomposities.
FI52575C (fi) Menetelmä kipua lievittävien substituoitujen N-sykloalkyyli-fenyyliami no-imidatsoliinien-(2) valmistamiseksi.
BE751536A (fr) Procede de preparation de l'isoprene
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
CA945473A (en) PROCESS FOR STABILIZATION OF A COMPOSITION OF 2.alpha.,3.alpha.-EPITHIO-ANDROSTANES AND COMPOSITION OBTAINED THEREBY
NL144592B (nl) Werkwijze voor de bereiding van 3,4-dihydroxyfenylalanine-verbindingen.
CA943137A (en) Process for racemizing optically active 3,4-dihydroxyphenylalanine and its derivatives
BE755403A (fr) Composition resineuse, son procede de preparation et ses applications
SE393802B (sv) Forfarande for framstellniog av i 3-stellning substituerade 1,2,3,4,5,6-hexahydro-2,6-metano-3-bensazocin-8-oler
PH10103A (en) 1)aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin 2-ones derivatives,its pharmaceutical composition and process of preparation
IL33821A (en) 1,3-dihydro-5-phenyl or pyridyl-2h-1,4-benzodiazepin-2-onederivatives,their preparation and pharmaceutical compositions containing them
CH513788A (fr) Procédé de préparation sélective d'alcool, estérifié de façon concomitante
IL34404A (en) Insecticidal compositions containing 2-chloro-2-thiono-1,3,2-dioxaphosphorinane derivatives and certain new compounds of this type
IL34549A0 (en) Benzofuran derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IT998182B (it) Fosforil 1,2,4 triazoli da impiegare come disinfestanti e procedimento per la loro preparazione
IL35232A (en) Anticonvulsive pharmaceutical compositions containing 3,3-dimethyl-1-phenyl-1-phthalane-acetamide
AU437447B2 (en) Process forthe preparation of 5 cyanopropyl) hydantoin
CA824164A (en) Aminoalkyl derivatives of 6,11-dihydro-dibenzo-b-e)-oxepine and -thiepine, process for their preparation and compositions thereof